|
| |
| | | 55976 | | 25.06.2002 | | Sandoz Pharmaceuticals AG | | 25.06.2007 | | | | | | | | | | | 07.08.20. | | | | 07.08.20. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Estradot 37.5 | Transdermales Pflaster | Transdermales Pflaster (Estradiol 585 µg) | G03CA03 | PI | | 02 | Estradot 50 | Transdermales Pflaster | Transdermales Pflaster (Estradiol 780 µg) | G03CA03 | PI | | 03 | Estradot 75 | Transdermales Pflaster | Transdermales Pflaster (Estradiol 1.17 mg) | G03CA03 | PI | | 04 | Estradot 100 | Transdermales Pflaster | Transdermales Pflaster (Estradiol 1.56 mg) | G03CA03 | PI | | 05 | Estradot 25 | Transdermales Pflaster | Transdermales Pflaster (Estradiol 390 µg) | G03CA03 | PI |
|
|
|
